Medicare's RAPID Rush for Instant Innovative Device Coverage Pathway
Published Date: 8/11/2026
Notice
Summary
This notice with comment period provides information to the public on the process CMS will use to provide accelerated Medicare coverage through the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway for new innovative technologies. The RAPID coverage pathway leverages existing processes to provide expedited national Medicare coverage for eligible technologies. This notice with comment period solicits public comment on the proposed RAPID coverage pathway.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 2 costs, 1 mixed.
Faster Medicare Coverage for Breakthrough Devices
If a qualifying Breakthrough-designated device meets the pathway rules and FDA gives market authorization, CMS will post a proposed National Coverage Determination (NCD) the same day as FDA authorization. CMS aims to finalize the NCD about 60 days later for Class II devices and about 90 days later for Class III devices, which could speed Medicare beneficiary access to those devices.
Who Can Use the RAPID Pathway
Only certain devices are eligible: presumptive Class II FDA Breakthrough-designated devices in TAP planning a De Novo request, or Class III FDA Breakthrough-designated devices planning a PMA application. The device must be in the IDE presubmission stage and the manufacturer must plan an IDE study that enrolls Medicare beneficiaries and evaluates clinical health outcomes that FDA and CMS agree are appropriate.
Diagnostic Tests (IVDs) Are Excluded
In vitro diagnostic products (IVDs), including diagnostic laboratory tests, will not be accepted into the RAPID coverage pathway in most cases. If an IVD and CMS agree an NCD is appropriate, the manufacturer may instead submit a traditional NCD request following existing procedures.
Higher-Risk Devices May Need More Evidence
Whether CMS requires additional evidence development (Coverage with Evidence Development, CED) will depend on device risk and the strength of IDE study results. Lower-risk devices are more likely to have enough evidence at FDA authorization, while higher-risk devices are more likely to need further evidence and aligned postmarket studies.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-15686, Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements
This final rule updates the hospice wage index, payment rates, and aggregate cap amount for fiscal year 2027. This final rule also includes an analysis of Medicare non-hospice spending, including details regarding a hospice service and spending variation index, and finalizes the requirement that hospices provide the hospice election statement addendum to all Medicare beneficiaries at the time of hospice election. Additionally, this rule finalizes conforming changes to discharge from hospice care regulations and changes to the face-to-face encounter regulations. This final rule also includes a summary of comments received on our requests for information regarding community- based palliative care; the construction of a hospice specific wage index; and the overlap between hospice and medical aid in dying laws. Finally, this rule finalizes changes to the Hospice Quality Reporting Program.
2026-15652, Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program
This final rule updates the prospective payment rates for inpatient rehabilitation facilities (IRFs) for Federal fiscal year (FY) 2027. As required by statute, this final rule includes the classification and weighting factors for the IRF prospective payment system's (PPS) case-mix groups and a description of the methodologies and data used in computing the prospective payment rates for FY 2027. It also finalizes the third and final of the 3-year phaseout of the rural adjustment, which began in FY 2025. This final rule includes a solicitation for public comments on alternative data sources for the IRF PPS wage index; requires all therapy treatments and/or therapy evaluations to begin no later than 36 hours from midnight on the day of admission; finalizes requirements for the initial Interdisciplinary Team meeting to occur on or before 4 days from the date the patient is admitted; and summarizes a request for information on potential future IRF PPS payment reform. Additionally, this final rule includes updates to the IRF Quality Reporting Program and changes to the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program.
2026-15562, Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027
Starting October 1, 2026, skilled nursing facilities (SNFs) will see updated payment rates and new rules for how Medicare pays them. The Quality Reporting and Value-Based Purchasing programs are also getting tweaks to help improve care. These changes affect SNFs nationwide and could impact how much money they get and how they report quality data.
2026-14897, Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes
Starting October 1, 2026, new rules will change how states handle health care-related taxes under Medicaid. These changes set clear limits on tax amounts based on 2025 levels and will gradually lower those limits in some states by 2027. States and taxpayers should get ready for tighter rules and better oversight that could affect tax collections and Medicaid funding.
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-14327, Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Starting in 2027, Medicare and Medicaid are updating how doctors and clinics get paid to better match today’s medical care and laws. This includes new rules for drug price rebates, shared savings programs, and payments for rural and specialty care. These changes affect doctors, patients, and drug makers, aiming to save money and improve care quality.
Previous / Next Documents
Previous: 2026-16367, Marine Mammals; Incidental Take During Specified Activities; Proposed Incidental Harassment Authorization for Southwest Alaska Stock of Northern Sea Otters in Unalaska, Alaska
We, the U.S. Fish and Wildlife Service (FWS), in response to a request under the Marine Mammal Protection Act of 1972, as amended, from the City of Unalaska, propose to authorize incidental take by harassment of small numbers of Southwest Alaska stock northern sea otters (Enhydra lutris kenyoni) for a period of up to 1 year from the date of issuance. The applicant has requested this authorization for take by harassment that may result from activities associated with pile driving and marine construction at the Robert Storrs Harbor in Unalaska, Alaska. This proposed authorization, if finalized, would be for incidental take by Level A harassment and Level B harassment of northern sea otters from the Southwest Alaska stock. We invite comments on the proposed incidental harassment authorization and the accompanying draft environmental assessment from the public, Tribes, and local, State, and Federal agencies.
Next: 2026-16369, Virginia Electric and Power Company, (Doing Business as Dominion Energy Virginia); North Anna Site; Early Site Permit Renewal Application
Dominion Energy Virginia wants to renew its early site permit for the North Anna nuclear site in Louisa County, extending it 20 more years past the current expiration in November 2027. This renewal lets them keep the option open to build or update nuclear facilities there without starting from scratch. The public can check out the application starting July 2026 and stay tuned for updates over the next few weeks.